Deepbridge Life Sciences EIS / SEIS – manager interview

We interview Ben Carter, investment director at Deepbridge Capital on the life sciences side, to discuss the Deepbridge Life Sciences EIS and SEIS funds, which invest in early- and growth-stage life sciences companies. 

Why should an investor look at the life sciences sector? What sort of companies do the funds invest in? What are some recent examples – and how are those companies doing since investment? What kind of exits could an investor hope for? And why should EIS and SEIS investors entrust their money to Deepbridge? Alex Davies, founder and chief executive of Wealth Club, talks to Ben Carter to find out.

Please note: the opinions expressed in this video are the interviewee’s own and do not necessarily reflect the view of Wealth Club Limited. This interview, like our service, is not advice nor a personal recommendation. The products featured are not suitable for everyone and capital is at risk. Tax benefits depend on circumstances and tax rules can change. Remember, past performance is not a guide to the future. Dividends are variable and not guaranteed. If you’re unsure an investment is right for you, please seek professional advice.

Deepbridge Life Sciences EIS

Read our review & download offer documents

Go to offer page